Carasent AB (publ)
OM:CARA
kr 22,50
kr0,00 (0,00%)
22,50 kr
kr0,00 (0,00%)
End-of-day quote: 03/20/2026

Carasent AB (publ) Stock Value

The current analyst rating for OM:CARA is sf_No Opinion.
sf_No Opinion

Carasent AB (publ) Company Info

EPS Growth 5Y
131,85%
Market Cap
kr1,54 B
Long-Term Debt
kr0,00 B
Quarterly earnings
04/14/2026
Dividend
kr0,00
Dividend Yield
0,00%
Founded
1997
Industry
Country
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

kr36,32
61.42%
61.42
Last Update: 03/22/2026
Analysts: 2

Highest Price Target kr39,90

Average Price Target kr36,32

Lowest Price Target kr32,74

In the last five quarters, Carasent AB (publ)’s Price Target has risen from kr26,50 to kr26,50 - a 0,00% increase. One analysts predict that Carasent AB (publ)’s share price will increase in the coming year, reaching kr36,32. This would represent an increase of 61,42%.

Top growth stocks in the health care sector (5Y.)

What does Carasent AB (publ) do?

Carasent AB (publ) engages in delivering cloud-based Electronic Health Record (EHR) solutions, with Webdoc serving as the primary platform alongside a comprehensive ecosystem of platform services. These services include innovations for patient communication and business intelligence. The company has shifted its focus toward the Webdoc X project, which is viewed as a higher-growth opportunity compared to its predecessor, Webdoc Norway. Targeting the German market offers the company favorable pro...
×